NCT02230917View on ClinicalTrials.gov

A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

June 30, 2016

Conditions
Multiple Myeloma
Interventions
DRUG

Sotatercept

DRUG

Placebo

Trial Locations (1)

46202

Indiana University Simon Cancer Center, Indianapolis

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Rebecca Silbermann

OTHER